Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monopar Therapeutics (MNPR) Shares Outstanding (2016 - 2020)

Historic Shares Outstanding for Monopar Therapeutics (MNPR) over the last 5 years, with Q3 2020 value amounting to $11.5 million.

  • Monopar Therapeutics' Shares Outstanding rose 2325.54% to $11.5 million in Q3 2020 from the same period last year, while for Sep 2020 it was $11.5 million, marking a year-over-year increase of 2325.54%. This contributed to the annual value of $10.6 million for FY2019, which is 1395.06% up from last year.
  • As of Q3 2020, Monopar Therapeutics' Shares Outstanding stood at $11.5 million, which was up 2325.54% from $10.7 million recorded in Q2 2020.
  • Monopar Therapeutics' Shares Outstanding's 5-year high stood at $11.5 million during Q3 2020, with a 5-year trough of $115894.0 in Q4 2016.
  • For the 5-year period, Monopar Therapeutics' Shares Outstanding averaged around $9.1 million, with its median value being $9.3 million (2017).
  • Its Shares Outstanding has fluctuated over the past 5 years, first surged by 791717.17% in 2017, then changed by 0.0% in 2018.
  • Monopar Therapeutics' Shares Outstanding (Quarter) stood at $115894.0 in 2016, then surged by 7917.17% to $9.3 million in 2017, then changed by 0.0% to $9.3 million in 2018, then grew by 13.95% to $10.6 million in 2019, then grew by 8.17% to $11.5 million in 2020.
  • Its Shares Outstanding stands at $11.5 million for Q3 2020, versus $10.7 million for Q2 2020 and $10.6 million for Q1 2020.